Exactly, multiple patented products in huge markets - Only thing holding this back is managements ability to capitalise on it due to a poor sales team and no real leaders, but with acuity's appointment and them finally admitting to past mistakes (to some degree) thanks to the ASX queries there looks to be a glimmer of hope here,
They know what they need to do - And they shouldn't be afraid to cut any under-performers from the companies payroll - This is a business after all, not a charity to those employed by it - Perhaps some on the board should remember that and shape up or ship out ASAP .
Dr. Rajen, there's a lot of your money on the line here, time to harden up and do what needs to be done - New appointments are needed IMO for this company to progress further, present appointments have all shown to be of no worth to the company or yourself.
Market cap is now a pittance for potential, will be watching for an entry, I think i will get one lower as i have a feeling someone else needs to buy back a few shares and won't be wanting to do it higher.
Good luck all.
- Forums
- ASX - By Stock
- get out while you can?
Exactly, multiple patented products in huge markets - Only thing...
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HCT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.788M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
HCT (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online